06 May 2020 – FT article highlights Coronavirus lessons for the fight against superbugs

Destiny Pharma targets infection prevention through its novel XF drugs and has the potential to be one of the leaders in the battle against superbugs. This FT article says COVID-19 pandemic has highlighted the critical need for such new drugs.